Vitamin D deficiency
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Informed consent signed by patient 2. Male and female patients aged 70 years and older 3. Diagnoses of osteoarthritis of the hip. 4. Baseline level of serum 25-OHD
Exclusion criteria
Exclusion criteria: 1. Unwillingness to cooperate with the study procedures 2. History of an active malignancy 3. Quetelet index (QI=weight in (kilogram)/ squire length (meters)) >40 4. History of chronic kidney disease (glomerular filtration rate (GFR)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effect of different doses cholecalciferol on serum 25-OHD | — |
Secondary
| Measure | Time frame |
|---|---|
| - To determine the effect of 150,000 vs 300,000 IU cholecalciferol on serum calcium and PTH on day 3, 5, 14 and after 6 weeks and 3 months - To determine the effect of surgery on the absorption of cholecalciferol - To determine the effect of surgery on serum calcium and PTH - To determine whether there is a wash-out period of the effect of cholecalciferol during 3 months of follow up - To determine changes in general well being measured by SF-12. | — |
Countries
Netherlands